IVF products approved in Russia

Vitrolife has obtained approval for its IVF nutrient solutions in Russia. Approval comprises 35 products.

“Russia is one of the markets that we have decided to focus on. Penetration for IVF is relatively low today, but it is assessed that this market can grow faster than average during the coming years” says Nils Sellbom, Director of Sales at Vitrolife.

14,000 infertility treatments are today carried out each year in Russia and the number of fertility clinics amounts to approximately 50. The potential market value for nutrient solutions and instruments for IVF thereby amounts to approximately SEK 30 million today.




April 10, 2008
Kungsbacka, Sweden

Magnus Nilsson
CEO








Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.